A collaboration between four MIT groups, led by principal investigators Laura L. Kiessling, Jeremiah A. Johnson, Alex K.

Human papillomavirus (virus like particle, 9-valent) vaccine is under clinical development by Merck and currently in Phase II for Human Papillomavirus Infections.

Bird flu has killed millions of fowl and infected, even killed, hundreds of humans. But the jump to cattle has experts ...

The spike protein decorates the exterior of coronavirus particles and enables a virus particle to bind to and infect a cell. Vaccines developed during the SARS-CoV-2 pandemic elicited an ...

Frustrated when Brazil could not get COVID vaccines, two Brazilian doctors (who have been best friends since college) decided ...

Proof-of-Concept Study to Find Functional Cure for HIV July 24, 2024 — Researchers conducted a breakthrough proof-of-concept study that found an HIV-like virus particle that could cease the need ...

According to the National Institutes of Health, although there are no approved norovirus vaccines, recent human clinical trials with virus-like particle-based vaccines have shown promise.

Many if not all of the body’s cells can make it. When the infective core of a virus particle invades a cell, that cell is usually doomed; its biochemical factory will soon be taken over by the ...

EV-D68 is part of a family of viruses known as enteroviruses, which are named for the transmission route, through the intestines. They are mainly spread through unwashed hands but can also be spread ...